Display Settings:

Format

Send to:

Choose Destination
N Engl J Med. 2012 Mar 1;366(9):844-6. doi: 10.1056/NEJMe1115119.

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms.

Comment in

  • Ruxolitinib for myelofibrosis. [N Engl J Med. 2012]

Comment on

PMID:
22375977
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk